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Gene transfer to primary corneal epithelial cells with an
integrating lentiviral vector
Transferência de genes heterólogos para células corneanas epiteliais primárias
utilizando vetor lentivírus
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ABSTRACT
Purpose: To evaluate the transfer of heterologous genes carrying a Green
Fluorescent Protein (GFP) reporter cassette to primary corneal epithelial cells
ex vivo.
Methods: Freshly enucleated rabbit corneoscleral tissue was used to obtain
corneal epithelial cell suspension via enzymatic digestion. Cells were plated
at a density of 5×103 cells/cm2 and allowed to grow for 5 days (to 70-80%
confluency) prior to transduction. Gene transfer was monitored using fluores-
cence microscopy and fluorescence activated cell sorter (FACS). We evaluated
the transduction efficiency (TE) over time and the dose-response effect of
different lentiviral particles. One set of cells were dual sorted by fluorescence
activated cell sorter for green fluorescent protein expression as well as
Hoechst dye exclusion to evaluate the transduction of potentially corneal
epithelial stem cells (side-population phenotypic cells).
Results: Green fluorescent protein expressing lentiviral vectors were able to
effectively transduce rabbit primary epithelial cells cultured ex vivo. Live cell
imaging post-transduction demonstrated GFP-positive cells with normal
epithelial cell morphology and growth. The transduction efficiency over time
was higher at the 5th post-transduction day (14.1%) and tended to stabilize
after the 8th day. The number of transduced cells was dose-dependent, and at
the highest lentivirus concentrations approached 7%. When double sorted by
fluorescence activated cell sorter to isolate both green fluorescent protein
positive and side population cells, transduced side population cells were
identified.
Conclusions: Lentiviral vectors can effectively transfer heterologous genes
to primary corneal epithelial cells expanded ex vivo. Genes were stably ex-
pressed over time, transferred in a dose-dependence fashion, and could be
transferred to mature corneal cells as well as presumable putative stem cells.
Keywords: Gene therapy; Corneal diseases; Lentivirus/genetics; Transgenes/
genetics; Stem cells; Epithelium corneal/physiology; Gene expression
RESUMO
Objetivo: Avaliar a transferência de genes heterólogos expressando a proteína
“Green Fluorescent Protein” (GFP) para células corneanas epiteliais primárias ex
vivo utilizando vetor lentivírus.
Métodos: Tecido corneoescleral de coelhos foi usado para obtenção de suspen-
são de células corneanas epitelias. As células foram semeadas na densidade de
5×103 células/cm2 e expandidas por 5 dias até uma confluência de 70-80% antes
de serem transduzidas. A transferência genética foi monitorada por microscopia
fluorescente e por um separador de células ativadas por fluorescência. Foram
avaliadas a eficiência de transdução ao longo do tempo e o efeito dose-resposta
de diferentes quantidades de partículas virais. Um grupo de células foi analisado
pelo separador de células ativadas por fluorescência para avaliar a transdução
de células com fenótipo de células tronco do epitélio corneano (baseado na
exclusão do corante “Hoechst dye”).
Resultados: Os vetores lentivírus foram efetivos na transdução de células cor-
neanas epiteliais primárias de coelhos ex vivo. Fotodocumentação das células
vivas demonstrou células epiteliais de morfologia normal e expressando o gene
fluorescente (GFP). A eficiência de transdução ao longo do tempo foi maior no
quinto dia após a transdução (14,1%) e demonstrou uma tendência à estabilida-
de a partir do oitavo dia após a transdução. O número de células transduzidas foi
dose-dependente e atingiu 7% com as maiores concentrações de partículas
virais. Quando analisadas pelo separador de células ativadas por fluorescência
para detecção de células transduzidas e também de células que excluíram o
corante “Hoechst dye”, foi detectado que células com fenótipo de células tronco
do epitélio corneano (“side-population”) também foram transduzidas.
Conclusões: Os vetores lentivirais podem transferir genes heterolólogos para
células corneanas epiteliais primárias expandidas ex vivo de forma eficiente. Os
genes foram expressos de forma estável ao longo do tempo e puderam ser
transferidos tanto para células epiteliais maduras como para presumíveis células
tronco epiteliais. A eficiência de transdução foi obtida de forma dose-dependente.
Descritores: Terapia de genes; Doenças da córnea; Lentivírus/genética; Tran-
genes/genética; Células tronco; Epitélio anterior; Expressão gênica
INTRODUCTION
Great progress has been made in molecular cell biologyand genetics to understand the basic cellular mechanismand the potential for genetic therapy. Technological
advances in that field, especially in recombinant DNA techniques,
have enabled scientists to develop gene therapy techniques for
the treatment of human diseases. It is an approach that offers
potential to cure diseases or abnormal medical conditions by
transferring new genetic material to target cells/tissue. Gene
therapy has the advantage of modulating pathophysiological di-
seases at the molecular level, which offers the potential to cure
them, or at least to promote long term therapeutical benefits,
instead of transient benefits with conventional pharmacotherapy.
An efficient gene delivery system is essential to transfer
genes to live cells and tissues. Vectors can be distinguished by
their ability to integrate genetic material in the target cell geno-
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me. Gene transfer can be stable or transient according to the
vectors’ ability to integrate the genetic material into the host
genome or not(1-2).
Basically, gene delivery systems can be broadly classified in
two categories: methods mediated by viral vectors and me-
thods using non-viral vectors. Viral methods are capable of
delivering genes at high efficiency for longer periods of time
compared to the non-viral methods. Nevertheless, these me-
thods may pose safety threats to patients and the environment.
Genes can also be delivered using non-viral methods. These
methods require plasmid vector for delivery of genes of interest
into cells. Several methods have been developed, including
mechanical, electrical, and chemical approaches. Synthetic DNA
delivery systems are versatile and safe, but substantially less
efficient in delivering genetic material than viral vectors. In ge-
neral, these methods are non-toxic and non-pathogenic and do not
trigger strong immune responses in the host. They still may be very
useful for situations where only transient gene expression is
required such as in corneal wound healing(1-2).
The cornea is an excellent candidate for gene therapy
because of its accessibility and immune-privileged nature.
Furthermore, the cornea epithelium can be maintained in stan-
dard culture conditions for extended periods of up to 1 month
prior to transplantation, which allows opportunities for genetic
modification prior to reintroduction into patients. The epithe-
lial layer, which is renewed by corneal epithelial stem cells,
plays a relevant role promoting protection and refractive pro-
perties essential for vision(3-7). As current techniques for re-
constructing the ocular surface damaged by stem cell defi-
ciency involve transplantation of expanded corneal epithelial
cells ex vivo(8-9), the epithelial layer, including presumed limbal
stem cells, becomes an attractive target for gene therapy to
ocular surface diseases.
This study investigates the feasibility of transducing rabbit
primary corneal epithelial cells as well as side population phe-
notypic corneal epithelial cells using a lentiviral vector carrying
a green fluorescent protein (GFP) reporter cassette ex vivo. We
sought to evaluate the expression of transduced genes over
time and the dose-response effect of lentiviral particles (cfu/mL)
used for transduction.
METHODS
PREPARATION OF RABBIT LIMBAL EPITHELIAL CELL SUSPENSION
All investigations were carried out in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research and with federal, state, and local regulations.
New Zealand white rabbits were euthanized with an over-
dose of 50 mg/kg ketamine and 7.5 mg/kg xylasine intramus-
cularly and an additional air injection in the ear vein (5cc).
Conjunctival peritomy was performed and the entire cornea
was excised including a 1.0 mm scleral rim. Rabbit keratolim-
bal tissue was divided into quadrants and placed epithelium
side down in 50mg/mL Dispase II solution (37°C and 5% CO
2
)
for one hour. After chemical digestion, the limbal epithelial
sheets were released from the explants using a sterile spatula
with a blunt blade. The sheets were pelleted by centrifuga-
tion at 1000g for five minutes and after removal of the super-
natant, they were incubated for 15 minutes at 37°C and 5%
CO
2 
in a 0.25% trypsin and 0.1% EDTA 0.1% solution. Trypsin
was neutralized and the cells resuspended in EpiLife® Medium
(Cascade Biologics, Portland, OR) supplemented with 1%
Human Keratinocyte Growth Supplement (Cascade Biologics,
Portland, OR; containing 0.2% bovine pituitary extract + 5 μg/mL
bovine insulin + 0.18 μg/mL hydrocortisone 0.18 + 5 μg/mL
bovine transferrin + 0.2 ng/mL human epidermal growth factor),
with 1% PSG + amphotericin B (penicillin G sodium 10000 μg/mL,
streptomycin sulfate 25 μg/mL, amphotericin B in 0.85%
saline - Gibco - Invitrogen Corporation), 5% fetal bovine
serum (FBS), 10 μg/mL mouse epidermal growth factor, and
10-10 M cholera toxin A. The cells were plated at a density of
5 x 103 cells/cm2 on 35 mm tissue culture dishes with cover
glass bottoms (World Precision Instruments, Inc.). Cells were
cultured up to 4 days and the medium changed every 48
hours. Transduction was performed when cells were 70% - 80%
confluent.
GENERATION OF LENTIVIRUS VECTOR
Using a TOPO® Cloning Reaction (Invitrogen) we cloned
our insert DNA (pIRES-AcGFP) containing a green fluorescent
protein (GFP) reporter cassette into an entry clone pENTR™
TOPO® vector (following manufacturer’s instructions). The in-
sert DNA was transferred into the destination vector pLenti4/
TO/V5-DEST (Invitrogen) by performing the LR recombination
reaction (LR Clonase™ II enzyme mix, Invitrogen) using One
Shot® Stbl3™ Competent E. coli (Invitrogen), resulting in the
generation of our pLenti4/TO/V5-Dest/IRES-AcGFP vector.
We used the ViraPower™ Packaging Mix (Invitrogen), which
contains an optimized mixture of three plasmids, pLP1, pLP2,
and pLP/VSVG, to produce the lentivirus. Replication-defective
VSV-G pseudotyped viral particles were produced by three-
plasmid transient cotransfection with the pLenti4/TO/V5-DEST
containing GFP-gene into the 293T cell line. Viral supernatants
were harvested 48 and 72 hours after transfection, centrifuged
at 3000 rpm for 15 minutes at 4°C, filtered trough 0.45 μm pore
size filters (Millipore Corporation) and stored at -80°C.
Viral vector titers were determined by transduction of
HT1080 cells with serially diluted virus supernatants. Transdu-
ced cells were counted based on expression of the green fluo-
rescent protein.
CYTOFLUORIMETRIC ANALYSIS OF TRANSDUCED CELLS
Transduction efficiency of pLenti4/TO/V5-Dest/IRES-
AcGFP on rabbit corneal epithelial cells was determined by
using a fluorescence-activated cell sorter (FACS) (DakyoCyto-
mation MoFlo Cell Sorter, Ft. Collins, CO) and a FACScan
Cytometer (BD Biosciences, San Jose, CA). For the sorting, we
used Summit software, the Enterprise laser with 200 mW of
488 nm, and a 530/30 band-pass filter to detect GFP. For the
FACScan, we used CellQuest software, a laser with 15 mW of
488 nm, and a 530/30 band-pass filter to detect GFP.
TRANSDUCTION EFFICIENCY (TE) OVER TIME
After 4-5 days post-transfection, cultured cells were
harvested and incubated with 2 μg/mL propidium iodide (PI)
(to exclude non-viable cells). They were then analyzed on the
FACScan for evaluation of the percentage of the GFP-ex-
pressing cells. Infected cells were detected on the basis of GFP
fluorescence relative to uninfected control. The TE was ana-
lyzed at days 0, 3, 5, 8, 11, and 15 post-transfection. We used
four cell culture dishes for each analyzed day (n=4).
DOSE-RESPONSE EFFECT ON LENTIVIRAL TRANSDUCTION EFFICIENCY
Transfection was performed using different lentiviral parti-
cles (0 cfu/mL, 102 cfu/mL, 103 cfu/mL, 5 x 103 cfu/mL, 104 cfu/mL,
2 x 104 cfu/mL). The cells were harvested and incubated with
2 μg/ml PI prior to analysis by FACScan. They were then
analyzed on the FACScan (5th post-transduction day) for eva-
luation of the percentage of the GFP-expressing cells. Infected
cells were detected on the basis of GFP fluorescence relative
to uninfected control. We used three cell culture dishes for
each lentiviral dilution analyzed (n=3).
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TRANSDUCTION OF SIDE POPULATION (SP) PHENOTYPIC CELLS
After 4 days post-transfection, cells were prepared for the
Hoechst 33342 assay. Hoechst 33342 exclusion assay and FACS
for SP were performed according to a previously described
method for isolating a SP for hematopoietic stem cells(8) using
Hoechst 33342. Transduced cells isolated from their primary
cultures were used for the Hoechst 33342 exclusion assay to
identify SP. The SP is characterized by low blue and low red
fluorescence intensity on a dot-plot displaying dual wave-
length of Hoechst blue versus red. This double sorting proce-
dure would allow isolation of presumed corneal epithelial
stem cells transduced with GFP-gene.
STATISTICAL ANALYSIS
The inferential analysis used in order to confirm or refute
the descriptive results was analysis of variance (ANOVA) to
compare the means of TE from different days analyzed in the
experiment “Transduction efficiency over time” and the
means of TE from different lentiviral particles analyzed in the
experiment “Dose-response effect on lentiviral transduction
efficiency”. α ≤ 0.05 was considered significant.
RESULTS
Viable cultures of rabbit corneal epithelial cells were obtai-
ned before transduction. GFP expressing lentiviral vectors
pLenti4/TO/V5-Dest/IRES-AcGFP were able to effectively trans-
duce primary rabbit corneal epithelial cell culture ex vivo. Live
cell imaging post-transduction demonstrated GFP-positive cells
with normal epithelial cell morphology and growth (Figure 1).
TRANSDUCTION EFFICIENCY OVER TIME
When measuring the TE over time we observed that it was
close to 7% at day 3 post-transduction and presented a peak of
efficiency at day 5 (14.1%). After that, the TE notably decreased
tending to stability around 4% to 5%. (Figure 2). The diffe-
rences in the median values among the different days analy-
zed were statistically significant (p=0.002).
The inferential results from ANOVA revealed that the six
analyzed days in the experiment A do not present the same
logarithmic mean of the measurements (p<0.001).
DOSE-RESPONSE EFFECT OF DIFFERENT LENTIVIRAL PARTICLES
The TE using different viral dilutions of our lentivirus vector
pLenti4/TO/V5-Dest/IRES-AcGFP during transduction was dose-
dependent, and approached an efficiency of approximately 7%
using 5 x 103 cfu/mL. It is interesting to note that higher amounts
of lentivirus particles did not increase the TE (Figure 3).
The inferential results from ANOVA revealed that the six
different lentiviral dilutions (cfu/mL) used in the Experiment B
did not present the same logarithmic mean of the measure-
ments (p=0.008).
TRANSDUCTION OF SIDE POPULATION PHENOTYPIC CELLS
When double sorted by FACS to isolate both GFP positive
and side population phenotypic cells, transduced side po-
pulation cells were identified. The TE in this experiment was
4.61%. The exclusion of Hoechst 33342 to identify the side
population was detected in 1.67% of the cells. After incuba-
tion with verapamil, the cells excluding the Hoechst 33342
dye approached 0.47% (Figure 4).
DISCUSSION
Previous investigators have demonstrated functional delivery
of genes by non-integrating methods into corneal cells by gene
gun(11), electroporation(12), and with adenoviral serotype 5 vec-
tors(13). However, these data were limited to corneal endothelial
cells of rat, mice, or rabbit. A few studies have been done
reporting gene delivery to primary corneal epithelial cells using
transient adenoviral vectors, which is known to promote a short-
term transgene expression that ceases after 7 -14 days(14-15).
Retrovirus has also been used to transduce corneal cells.
Some authors transduced rabbit corneal epithelial cells in vivo
and in vitro(16). Some authors demonstrated TE of 22% in human
keratocytes and 16% in rabbit keratocytes, ex vivo, using a
retroviral vector(17). Those studies demonstrated the retroviral
vector’s ability to transduce corneal cells and characterize
their stable gene expression.
The use of lentivirus vectors for corneal gene therapy is
appealing because the vector stably integrates into the host
genome, providing the potential for long-term transgene
expression. And different from retroviral vectors, lentiviral do
not require mitotic cells to integrate. They integrate into both
dividing and non-dividing cells. Wang et al detected gene
expression in epithelial and endothelial cells in situ during 60
days when transducing corneas preserved in tissue culture(18).
Another research group transduced rat cornea epithelial cells
in vivo using lentivirus. They demonstrated a more stable gene
expression in the group transduced by lentivirus, suggesting
their ability to integrate DNA to the host genome(19). Murthy
et al detected the expression of endostatin at the 40th post-
operative day of rabbit cornea transplantation previously
incubated with lentivirus vector(20).
In our experiment investigating the time-course of gene
expression following transduction we observed that 6.6% of
the cells were transduced at day 3. Then we observed a peak
in the TE at day 5, approaching 14.1%. After day 5 the TE
decreased and tended to stability around 4-5% (Figure 2).
These results suggest that presumable stem cells and
transient amplifying cells (TAC) were transduced. The trans-
duction of TAC might explain the massive transduction bet-
A B C
Figure 1. Live cell imaging post-transduction demonstrating GFP-positive cells with normal epithelial cell morphology and growth.
A) Fluorescence imaging; B) Phase-contrast of cultured corneal cells; C) Overlay.
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Figure 2. Representative histograms (propidium iodide X GFP) demonstrating the identification of GFP (+) cells by FACS for
each analyzed day. R3 corresponds to the gate used for isolation of cells expressing GFP. R4 corresponds to the gate used
for exclusion of dead cells. Box plot demonstrating the TE over time. The graphic demonstrates the percentage of viable GFP
(+) cells for each analyzed day (0, 3, 5, 8, 11, and 15).
ween days 3 and 5. A few studies described that TAC increase
in number after injury stimulation(4, 21). We believe that the TAC
cells were initially stimulated by lentiviral contact and increa-
sed their number. That would explain the TE’s peak between
days 3 and 5 post-transduction. After a few more days in
culture, and without other stimuli to differentiation, they
achieved maximum differentiation and started to become
nonviable cells. This might explain the TE’s decrease and its
tendency to stability after day 5. The inferential results bet-
ween the analyzed days did not show statistically significantly
differences in the TE between days 8 and 11 (p=0.6857),
neither between days 8 and 15 (p=0.1052) (Figure 2). Brads-
haw et al also observed an early peak of transduction poten-
tially related to TAC transduction. They reported a peak of TE
at day 7 post-transduction (using retrovirus) which decreased
from the first to the second week and then tended to stability
until 9 weeks(16). The tendency to stability is associated to the
lentiviral ability to integrate DNA to the host cells genome
and consequently to their progeny.
Another hypothesis for the peak observed between days 3
and 5 is that it might require some time for the lentivirus to
get into the cells and integrate their DNA. Also, the cell
machinery requires some time to express the genetic material
inserted. We have not yet examined this hypothesis since our
first point of analysis was on day 3.
Once we studied and characterized our vector’s ability to
transduce primary corneal epithelial cells ex vivo, we analyzed
the dose-effect response. The results demonstrated that the
TE was dose dependent comparing different lentiviral particles
(p=0.008). The highest TE(s) were obtained with 5 x 103 cfu/mL
and 104 cfu/mL lentiviral particles. The paired comparisons
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Figure 3. Representative histograms (propidium iodide X GFP) demonstrating the identification of GFP (+) cells by FACS for
each lentiviral particles dilution used. R3 corresponds to the gate used for isolation of cells expressing GFP. R4 corresponds to
the gate used for exclusion of dead cells. Box-plot demonstrating the dose-response effect in TE using different lentiviral
particles. It demonstrates the percentage of viable GFP (+) cells for each lentiviral dilution used in the Experiment B (0 cfu/mL, 102
cfu/mL, 103 cfu/mL, 5 x 103 cfu/mL, 104 cfu/mL, 2 x 104 cfu/mL).
between the two lentiviral particle dilutions with the other
dilutions showed statistically higher TE than the other lenti-
viral particles dilutions. Wang et al demonstrated a positive
correlation between the amount of lentiviral particles used to
transduce corneal cells and the TE obtained(18). It is relevant to
note in our study that higher virus concentration (2 x 104 cfu/mL)
did not result in higher TE. The TE obtained with this amount of
viral particles was lower than those obtained with 5 x 103 cfu/mL
and with 104 cfu/mL (p=0.0040 and p=0.0046, respectively).That
observation leads the suspicion of lentiviral toxicity to cultured
primary corneal epithelial cells. However, we did not observe
morphological cell changes and neither growth rate decrease
when we used higher lentivirus particles (data not shown). Also,
we did not consider the exclusion of nonviable cells by propi-
dium iodide assay as a parameter for toxicity. Two different
studies reported the possible GFP toxicity inducing cell apop-
tosis when measuring the activity of CPP32, a relevant protease in
the apoptotic process(16,22). The probability of lentiviral toxicity
associated with GFP toxicity might justify why the TE was not
higher when we used higher amounts of lentiviral particles.
Given the eventual desire to achieve long lasting gene
expression in the setting of gene therapy, we evaluated the
ability of our lentiviral vector to transduce a putative stem
cell population. The quest for unique markers of corneal epi-
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Figure 4. Representative histograms demonstrating the identification of transduced side population phenotypic
cells by FACS. A) Histogram (propidium iodide X forward scatter) isolating viable cells (gate R1: 43.80%). B)
Histogram (GFP X forward scatter) isolating GFP(+) cells (gate R4: 4.61%). C) Histogram (Hoechst blue X Hoechst red)
isolating side population phenotypic cells (gate R3: 1.67%). D) Histogram (Hoechst blue X Hoechst red) after
incubation with verapamil isolating the subpopulation “side population” (gate R3: 0.47%).
A B
C D
thelial stem cells continues, however, a number of inves-
tigators have isolated putative stem cells functionally as side
population cells based on their ability to efflux the Hoechst
33342 dye when sorted by FACS(10,23). Both human(24-25) and
rabbit limbal epithelial cells(26) have been sorted in order to
isolate the side population (SP) phenotypic cells. Additio-
nally, strong correlations with the expression of ABCG2 mar-
kers for human side population limbal cells have been re-
ported reinforcing the characterization of phenotypic corneal
epithelial stem cells(24-25). Our results are similar to others com-
paring the size of the side-population phenotypic cells found.
We detected that 0.47% of the cells in our cell suspension,
which was obtained from the limbal and whole cornea epi-
thelial layer, demonstrated that phenotype. Some authors,
using a cell suspension from rabbit’s limbal area, reported
that 0.40% of the cells demonstrated the side-population
phenotype(27). When double sorted by FACS using two diffe-
rent channels simultaneously, one to isolate GFP positive cells
and the other to isolate side population phenotypic cells,
transduced side population cells were identified.
While gene delivery to differentiated corneal epithelial cells
will likely have utility for a number of ocular surface diseases,
genetic modification of presumed corneal epithelial stem cells
may be promising by enabling the production of gene pro-
ducts in their progeny or by providing bioactive proteins to
the epithelium early in the repair process.
The use of transduced corneal epithelial cells may augment
our ability to treat severe ocular surface disease. Depletion of
stem cells leads to cornea vascularization, fibrous tissue growth,
and cornea opacification(28). Current techniques for reconstruc-
ting the ocular surface damaged by stem cell deficiency involve
transplantation of expanded corneal epithelial cells ex vivo, as
previously reported(8-9). Cell therapy is a typical example of
regenerative medicine. Gene therapy makes regenerative me-
dicine more attractive, since it allows modification of cellular
properties by gene introduction before transplanting the
tissue to the host. This combination allows exploration of the
potential to genetically transform cells that would promote
biochemical signals influencing cell proliferation and differen-
tiation, relevant steps in functional tissue repair.
CONCLUSIONS
Lentiviral vectors can effectively transfer heterologous ge-
nes to primary corneal epithelial cells expanded ex vivo. Genes
were stably expressed over time and could be transferred to
mature corneal cells as well as presumable putative stem cells.
Transduction efficiency was dose-dependent, however
concerns regarding toxicity need further investigation.
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